ASTRAZENECA PHARMA INDIA LTD.

Company Update

ASTRAZENECA PHARMA INDIA LTD. - 506820 - Statement Of Investor Complaints For The Quarter Ended December 2020

BSE India

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 1120 Name of the Signatory :- PRATAP RUDRADesignation :- Company Secretary and Compliance Officer

Comment

Name	Companies Held
Hitesh Ramji Javeri	50
Mahendra Girdharilal	50
Sangeetha S	50
Dheeraj Kumar Lohia	42
Mukul Agrawal	39

Name	Companies Held
Hdfc Trustee Company Limited	100
Reliance Capital Trustee C...	87
Birla Sun Life Trustee Com...	62
President Of India	54
General Insurance Corporat...	51

Name	Returns(%)
Name	Week	Month	Year
Quant Active Fund - Reg - G	2.55%	5.23%	62.24%
ICICI Prudential Focused Equity Fund - Reg - G	2.36%	1.44%	45.64%
Quant Focused Fund - Reg - G	2.80%	3.74%	42.42%
HDFC Growth Opportunities Fund - Reg - G	3.22%	5.34%	41.21%
UTI - Core Equity Fund - Reg - G	3.16%	4.61%	41.14%

Name	Returns(%)
Name	Week	Month	Year
DHFL Pramerica Midcap Opportunities Fund - Reg - G	1.85%	5.02%	63.32%
Kotak Small Cap Fund - Reg - G	3.00%	9.69%	57.92%
Reliance Small Cap Fund - Reg - G	4.25%	10.20%	53.47%
SBI MAGNUM MIDCAP FUND - Reg - G	1.73%	8.10%	48.91%
Reliance Focused Equity Fund - Reg - G	1.96%	5.35%	48.58%

Name	Returns(%)
Name	Week	Month	Year
DHFL Pramerica Diversified Equity Fund - Reg - G	1.64%	1.24%	50.59%
Quant Mid Cap Fund - Reg - G	3.84%	5.51%	49.34%
Templeton India Value Fund (erstwhile known as Templeton India Growth Fund) - Reg - G	2.70%	4.70%	48.97%
Franklin India Opportunities Fund - Reg - G	2.55%	1.31%	48.48%
ICICI Prudential Value Discovery Fund - Reg - G	2.84%	2.42%	46.93%

ASTRAZENECA PHARMA INDIA LTD. - 506820 - Statement Of Investor Complaints For The Quarter Ended December 2020

Now Trending